Ligand Pharmaceuticals Incorporated (LGND) vs Mirum Pharmaceuticals, Inc. (MIRM)
- Ligand Pharmaceuticals Incorporated LGND 306.43 +2.48%
- Mirum Pharmaceuticals, Inc. MIRM 93.82 +0.30%
Ligand Pharmaceuticals Incorporated and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Ligand Pharmaceuticals Incorporated and Mirum Pharmaceuticals, Inc. are of similar size ($6.1B and $6.0B). Mirum Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 116×. Mirum Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 42.2% against 1.03%. Ligand Pharmaceuticals Incorporated has the higher net margin (20.3% vs −134.8%) and the higher return on invested capital (1.27% vs −184.7%). Across the 16 metrics below, Ligand Pharmaceuticals Incorporated leads on 10 and Mirum Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | LGND | MIRM | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.22% | 81.72% | 65.16% |
| Operating margin | 9.29% | (133.62%) | 0.00% |
| Net margin | 20.27% | (134.75%) | 0.00% |
| Free cash flow margin | 31.43% | (46.04%) | 0.00% |
| Return on equity | 5.38% | (760.01%) | (50.12%) |
| Return on assets | 2.77% | (99.78%) | (45.60%) |
| Return on invested capital | 1.27% | (184.65%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack